THE AMAZING RESULTS
- 91% of people noticed a significant decrease in skin imperfections already after the first 2 weeks of application
- 93% of people show significantly more luminous and uniform complexion
- 90% of people noticed a decrease in skin dyschromia
- 85% experienced cell renewal
- 100% of those who have tried it, have noticed an improvement in the appearance and texture of the skin
*all results are based on a sample of 30 women between the ages of 25 and 55.
Results may vary from person to person
This next-generation polyhydroxy acid has intense skin moisturising properties. It prevents free radicals forming in the skin with an anti-oxidant action that is particularly useful for preventing skin ageing, leaving skin more youthful, brighter and evenly-textured. It reduces melanin levels for a gentle lightening effect.
AQUA, LACTOBIONIC ACID, PROPANEDIOL, GLYCERIN, AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER, PHENOXYETHANOL, CAPRYLYLGLYCOL, 1,2-HEXANEDIOL, XANTHAN GUM, ETHYLHEXYLGLYCERIN, TROPOLONE.
EXFOLIATING ACTION:The high concentration of Lactobionic Acid guarantees an intense but delicate exfoliation of the stratum corneum, promoting cell turnover and cell renewal.
REDUCES SKIN DYSCHROMIA: Lactobionic Acid reduces the melanin index of the skin and also has a brightening effect.
MORE LUMINOUS AND UNIFORM SKIN: to be used with constancy for an extra revitalization of the skin and
to erase the signs of aging. Provides more radiance and a more homogeneous complexion by attenuating dyschromia. A ritual to be repeated every morning and evening for a special pampering.
OUR DIFFERENCE IS OUR QUALITY: Compared to most serums, our Lactobionic Acid Shot contains only Lactobionic Acid which has a significant antioxidant action preventing the formation of free radicals
YOUR BEAUTY ROUTINE
Apply morning and evening to washed and cleansed skin for about one week and massage gently. It is a gentle exfoliator and can also be used under your usual face cream.
YOUR HEALTH SAFETY
To guarantee product reliability and safety, an in vitro study of compatibility was initiated by Kosmolab of DISTAV – University of Genoa, as part of the INT.E.G.RA partnership.